Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
Sign Up to like & getrecommendations! Published in 2017 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-017-3624-y
Abstract: PurposeTo evaluate the visual and anatomical outcomes following switching therapy from bevacizumab to aflibercept in patients with persistent diabetic macular edema (DME).MethodsPatients with DME and central macular thickness (CMT) >300 μm on spectral domain optical coherence… read more here.
Keywords: bevacizumab aflibercept; bevacizumab; diabetic macular; switching therapy ... See more keywords
Neoadjuvant Therapy of Cervical Carcinoma with the Angiogenesis Inhibitor Bevacizumab: a Single-Centre Analysis
Sign Up to like & getrecommendations! Published in 2018 at "Geburtshilfe und Frauenheilkunde"
DOI: 10.1055/a-0641-5588
Abstract: Introduction Cervical cancer is the fourth most frequent cancer in women worldwide. Addition of the VEGF antibody bevacizumab in combination with platinum-containing chemotherapy achieved an improvement in overall survival in advanced cervical cancer. To date… read more here.
Keywords: bevacizumab; combined therapy; cervical cancer; therapy ... See more keywords